Hot spots and future directions of research on the neuroprotective effects of nimodipine
- PMID: 25558246
- PMCID: PMC4281435
- DOI: 10.4103/1673-5374.145365
Hot spots and future directions of research on the neuroprotective effects of nimodipine
Abstract
Calcium antagonists are widely used in the clinical treatment of ischemic cerebrovascular disease because of their vascular and neuroprotective effects. Nimodipine, a typical calcium antagonist, can cross the blood-brain barrier and act selectively at neurons and blood vessels of target tissues, thus exerting neuroprotective effects. The aim of the present study was to explore the hot spots and future trends of research on the neuroprotective effects of nimodipine. We retrieved 425 articles on the neuroprotective effects of nimodipine that were indexed in the Web of the Science database between 2000 and 2014. The retrieved articles were analyzed using document analysis reporting and the derived information function in the Web of Science, and the information visualization software CiteSpace III. The reference co-citation network was plotted, and the high frequency key words in these publications were used to analyze the research fronts and development trends for nimodipine neuroprotection. According to these co-citation clusters, the research front of nimodipine neuroprotection is the use of randomized controlled trials to study nimodipine intervention of subarachnoid hemorrhage. Using time zone view analysis on hot spots labeled with a key word, the areas of interest in the field of nimodipine neuroprotection are nimodipine pharmacology and therapeutics, blood-brain barrier, trials, and anti-angiospasm.
Keywords: CiteSpace; Web of Science; development trends; ischemic cerebrovascular disease; nerve regeneration; neuroprotection; nimodipine; research fronts; scientific mapping; visualization.
Figures








Similar articles
-
Visualization analysis of research frontiers and trends in nerve regeneration and osseoperception in the repair of tooth loss.Neural Regen Res. 2014 Nov 15;9(22):2013-8. doi: 10.4103/1673-5374.145385. Neural Regen Res. 2014. PMID: 25598785 Free PMC article.
-
Sciatic nerve injury repair: a visualized analysis of research fronts and development trends.Neural Regen Res. 2014 Sep 15;9(18):1716-22. doi: 10.4103/1673-5374.141810. Neural Regen Res. 2014. PMID: 25374595 Free PMC article.
-
From pharmacological promises to controlled clinical trials to meta-analysis and back: the case of nimodipine in cerebrovascular disorders.Clin Trials Metaanal. 1994 Apr;29(1):57-79. Clin Trials Metaanal. 1994. PMID: 10150186
-
Neuroprotection in acute stroke.Ann Acad Med Singap. 2001 Mar;30(2):134-42. Ann Acad Med Singap. 2001. PMID: 11379410 Review.
-
Nimodipine and its use in cerebrovascular disease: evidence from recent preclinical and controlled clinical studies.Clin Exp Hypertens. 2008 Nov;30(8):744-66. doi: 10.1080/10641960802580232. Clin Exp Hypertens. 2008. PMID: 19021025 Review.
Cited by
-
Safety and efficacy of nimodipine combined with flunarizine in patients with angioneurotic headache.Am J Transl Res. 2022 Jan 15;14(1):511-517. eCollection 2022. Am J Transl Res. 2022. PMID: 35173871 Free PMC article.
-
Bibliometric Analysis of Algal-Bacterial Symbiosis in Wastewater Treatment.Int J Environ Res Public Health. 2019 Mar 26;16(6):1077. doi: 10.3390/ijerph16061077. Int J Environ Res Public Health. 2019. PMID: 30917551 Free PMC article.
-
Mapping the coevolution, leadership and financing of research on viral vectors, RNAi, CRISPR/Cas9 and other genomic editing technologies.PLoS One. 2020 Apr 15;15(4):e0227593. doi: 10.1371/journal.pone.0227593. eCollection 2020. PLoS One. 2020. PMID: 32294089 Free PMC article.
-
Nimodipine Treatment Protects Auditory Hair Cells from Cisplatin-Induced Cell Death Accompanied by Upregulation of LMO4.Int J Mol Sci. 2022 May 21;23(10):5780. doi: 10.3390/ijms23105780. Int J Mol Sci. 2022. PMID: 35628594 Free PMC article.
-
Nimodipine protects Schwann and neuronal cells from cell death induced by cisplatin without affecting cancer cells.Sci Rep. 2025 Jun 25;15(1):20279. doi: 10.1038/s41598-025-06854-5. Sci Rep. 2025. PMID: 40562831 Free PMC article.
References
-
- Ahmed N, Näsman P, Wahlgren NG. Effect of intravenous nimodipine on blood pressure and outcome after acute stroke. Stroke. 2000;31:1250–1255. - PubMed
-
- Allen GS, Ahn HS, Preziosi TJ, Battye R, Boone SC, Boone SC, Chou SN, Kelly DL, Weir BK, Crabbe RA, Lavik PJ, Rosenbloom SB, Dorsey FC, Ingram CR, Mellits DE, Bertsch LA, Boisvert DP, Hundley MB, Johnson RK, Strom JA, Transou CR. Cerebral arterial spasm--a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med. 1983;308:619–624. - PubMed
-
- Babu CS, Ramanathan M. Post-ischemic administration of nimodipine following focal cerebral ischemic-reperfusion injury in rats alleviated excitotoxicity neurobehavioural alterations and partially the bioenergetics. Int J Dev Neurosci. 2011;29:93–105. - PubMed
-
- Barker FG, 2nd, Ogilvy CS. Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: a metaanalysis. J Neurosurg. 1996;84:405–414. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources